Cloning and expression of murine sister of P-glycoprotein reveals a more discriminating transporter than MDR1/P-glycoprotein

Molecular Pharmacology

Volumn 57, Issue 1, 2000, Pages 24-35

  Lecureur, Valerie ^a   Sun, Daxi ^a   Hargrove, Philip ^a   Schuetz, Erin G ^a   Kim, Richard B ^b   Lan, Lu Bin ^a   Schuetz, John D ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCEIN; COMPLEMENTARY DNA; CYCLOSPORIN A; DAUNORUBICIN; DIGOXIN; DITEKIREN; GLYCOPROTEIN P; GREEN FLUORESCENT PROTEIN; MULTIDRUG RESISTANCE PROTEIN; PACLITAXEL; RESERPINE; RHODAMINE 123; TAUROCHOLIC ACID; VINBLASTINE;

ANIMAL CELL; ARTICLE; CHROMOSOME 2; CONTROLLED STUDY; DOG; DRUG UPTAKE; HUMAN; HUMAN CELL; KIDNEY CELL; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT;

AMINO ACID SEQUENCE; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; CELLS, CULTURED; CLONING, MOLECULAR; DNA, COMPLEMENTARY; HUMANS; KARYOTYPING; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; P-GLYCOPROTEIN; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 0033989134     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Bakos E, Evers R, Szakacs G, Tusnady GE, Welker E, Szabo K, de Haas M, van Deemter L, Borst P, Baradi A and Sarkadi B (1998) Functional multidrug resistance protein (MRP1) lacking the N-terminal transmembrane domain. J Biol Chem 48:32167-32175.
2. Beher WT, Filus AM, Rao B and Beher ME (1969) A comparative study of bile acid metabolism in the rat, mouse, hamster, and gerbil. Proc Soc Exp Biol Med 130: 1067-1074.
3. Boyer J, Hagenbuch B, Ananthanarayanan M, Suchy F, Stieger B and Meier P (1993) Phylogenetic and ontogenic expression of hepatocellular bile acid transport. Proc Natl Acad Sci USA 90:435-438.
4. Chan FK and Schaffer EA (1997) Cholestatic effects of cyclosporin in the rat. Transplantation 63:1574-1578.
5. Childs S, Lin Yeh E, Hui D and Ling V (1998) Taxol resistance mediated by transfection of the liver-specific sister gene of P-glycoprotein. Cancer Res 58:4160-4167.
6. Childs S, Yeh RL, Georges E and Ling V (1995) Identification of a sister gene to P-glycoprotein. Cancer Res 55:2029-2034.
7. Crocenzi FA, Sisti A, Pellegrino JM and Roma MG (1997) Role of bile salts in colchicine-induced hepatotoxicity. Implications for hepatocellular integrity and function. Toxicology 121:127-142.
8. Dubuisson C, Cresteil D, Desrochers M, Decimo D, Hadchouel M and Jacquemin E (1996) Ontogenic expression of the Na(+)-independent organic anion transporting polypeptide (oatp) in rat liver and kidney. J Hepatol 25:932-940.
9. Essodaigui M, Broxterman HJ and Garnier-Suillerot A (1998) Kinetic analysis of calcein and calcein-acetoxymethylester efflux mediated by the multidrug resistance protein and P-glycoprotein. Biochemistry 37:2243-2250.
10. Gerloff T, Stieger B, Hagenbuch B, Madon J, Landmann L, Roth J, Hofmann AF and Meier PJ (1998) The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver. J Biol Chem 273:10046-10050.
11. Homolya L, Hollo Z, Germann UA, Pastan I, Gottesman MM and Sarkadi B (1993) Fluorescent cellular indicators are extruded by the multidrug resistance protein. J Biol Chem 268:21493-21496.
12. Katagiri K, Nakai T, Hoshino M, Hayakawa T, Ohnishi H, Okayama Y, Yamada T, Ohiwa T, Miyaji M and Takeuchi T (1992) Tauro-beta-muricholate preserves choleresis and prevents taurocholate-induced cholestasis in colchicine-treated rat liver. Gastroenterology 102:1660-1667.
13. Kitazawa T, Terasaki T, Suzuki H, Kakee A and Sugiyama Y (1998) Efflux of taurocholic acid across the blood-brain barrier: Interaction with cyclic peptides. J Pharmacol Exp Ther 286:890-895.
14. Kozak M (1989) A scanning model for translation: An update. J Cell Biol 108:229-241.
15. Lammert F, Beier DR, Wang DO, Carey MC, Paigen B and Cohen DE (1997) Genetic mapping of hepatocanalicular transporters establishes sister-P-glycoprotein (spgp) as a candidate for the major gallstone gene (Lith 1). Hepatology 26:358A.
16. Mayer U, Wagenaar E, Dorobek B, Beijnen JH, Borst P and Schinkel AH (1997) Full blockade of intestinal P-glycoprotein and extensive inhibition of blood-brain barrier P-glycoprotein by oral treatment of mice with PSC833. J Clin Invest 100: 2430-2436.
17. Nijbroek GL and Michaelis S (1998) Functional assays for analysis of yeast ste6 mutants. Methods Enzymol 292:193-212.
18. Persons DA, Mehaffey MG, Kaleko M, Nienhuis AW and Vanin EF (1998) An improved method for generating retroviral producer clones for vectors lacking a selectable marker gene. Blood Cells Mol Dis 24:167-182.
19. Rao VV, Dahlheimer JL, Bardgett ME, Snyder AZ, Finch RA, Sartorelli AC and Piwnica-Worms D (1999) Choroid plexus epithelial expression of MDR1 P-glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier. Proc Natl Acad Sci USA 96:3900-3905.
20. Raymond M and Gros P (1989) Mammalian multidrug-resistance gene: Correlation of exon organization with structural domains and duplication of an ancestral gene. Proc Natl Acad Sci USA 86:6488-6492.
21. Raymond M, Rose E, Housman DE and Gros P (1990) Physical mapping, amplification, and overexpression of the mouse mdr gene family in multidrug-resistant cells. Mol Cell Biol 10:1642-1651.
22. Ruetz S, Brault M, Dalton W and Gros P (1997) Functional interactions between synthetic alkyl phospholipids and the ABC transporters P-glycoprotein, Ste-6, MRP, and Pgh-1. Biochemistry 38:8180-8188.
23. Safa AE, Stern RK, Choi K, Agresti M, Tamai I, Mehta ND and Roninson IB (1990) Molecular basis of preferential resistance to colchicine in multidrug-resistant human cells conferred by Gly-185 - Val-185 substitution in P-glycoprotein. Proc Natl Acad Sci USA 87:7225-7229.
24. Sarkadi B, Muller M, Homolya L, Hollo Z, Seprodi J, Germann UA, Gottesman MM, Price EM and Boucher RC (1994) Interaction of bioactive hydrophobic peptides with the human multidrug transporter. FASEB J 10:766-770.
25. Schinkel AH, Mayer U, Wagenaar E, Mol CAAM, van Deemter L, Smit JJM, van der Valk MA, Voordouw AC, Spits H, van Tellingen O, Zijlmans J, Fibbe WE and Borst P (1997a) Normal viability and altered pharmacokinetics in mice lacking mdrl-type (drug-transporting) P-glycoproteins. Proc Natl Acad Sci USA 94:4028-4033.
26. Schinkel AH, Wagenaar E, Mol C and van Deemter L (1997b) P-glycoprotein in the Blood-Brain Barrier of Mice Influences the Brain Penetration and Pharmacological Activity of Many Drugs. J Clin Invest 97:2517-2524.
27. Schuetz EG, Furuya KN and Schuetz JD (1995a.) Interindividual variation in expression of P-glycoprotein in normal human liver and secondary hepatic neoplasms. J Pharmacol Exp Ther 275:1011-1018.
28. Schuetz JD, Molowa DT and Guzelian PS (1989) Characterization of a cDNA encoding a new member of the glucocorticoid-responsive cytochromes P450 in human liver. Arch Biochem Biophys 274:355-365.
29. Schuetz JD and Schuetz EG (1993) Extracellular matrix regulation of multidrug resistance in primary monolayer cultures of adult rat hepatocytes. Cell Growth Differ 4:31-40.
30. Schuetz JD, Silverman JA, Thottassery JV, Furuya KN and Schuetz EG (1995b) Divergent regulation of the class II P-glycoprotein gene in primary cultures of hepatocytes versus H35 hepatoma by glucocorticoids. Cell Growth Differ 6:1321-1332.
31. Sinicrope FA, Dudeja PK, Bissonnette BM, Safa AR and Brasitus TA (1992) Modulation of P-glycoprotein-mediated drug transport by alterations in lipid fluidity of rat liver canalicular membrane vesicles. J Biol Chem 267:24995-25002.
32. Sparreboom A, van Asperen J, Mayer U, Schinkel AH, Smit JW, Meijer D, Borst P, Nooijen WJ, Beijnen JH and van Tellingen O (1997) Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine. Proc Natl Acad Sci USA 94:2031-2035.
33. Strautnieks SS, Bull LN, Knisely AS, Kocoshis SA, Dahl N, Arnell H, Sokal E, Dahan K, Childs S, Ling V, Tanner MS, Kagalwalla AF, Nemeth A, Pawlowska J, Baker A, Mieli-Vergani G, Freimer NB, Gardiner RM and Thompson RJ (1998) A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat Genet 20:233-238.
34. 61 position in predicted transmembrane domain 1 of human MDR1/P-glycoprotein. Biochemistry 36:8883-8889.
35. Takahashi H, Kim RB, Perry PR and Wilkinson GR (1997) Characterization of the hepatic canalicular membrane transport of a model oligopeptide: Ditekiren. J Pharmacol Exp Ther 281:297-303.
36. Tiberghien F and Loor F (1996) Ranking of P-glycoprotein substrates and inhibitors by a calcein-AM fluorometry screening assay. Anticancer Drugs 7:568-578.
37. Torok M, Gutmann H, Fricker G and Drewe J (1999) Sister of P-glycoprotein expression in different tissues. Biochem Pharmacol 57:833-835.
38. Watanabe T, Miyauchi S, Sawada Y, Iga T, Hanano M, Inaba M and Sugiyama Y (1992) Kinetic analysis of hepatobiliary transport of vincristine in perfused rat liver. Possible roles of P-glycoprotein in biliary excretion of vincristine. J Hepatol 16:77-88.
39. Yang Y, Vanin EF, Whitt M, Fornerod M, Zwart R, Schneiderman RD, Grosveld G and Nienhuis AW (1995) Inducible, high-level production of infectious murine leukemia retroviral vector particles pseudotyped with vesicular stomatitis virus G envelope protein. Hum Gene Ther 6:1203-1213.
40. Yonekura H, Nata K, Watanabe T, Kurashina Y, Yamamoto H and Okamoto H (1988) Mosaic evolution of prepropancreatic polypeptide. II. Structural conservation and divergence in pancreatic polypeptide gene. J Biol Chem 263:2990-2997.